IBDEI0HO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8244,0)
 ;;=281.9^^35^482^107
 ;;^UTILITY(U,$J,358.3,8244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8244,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,8244,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,8244,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,8245,0)
 ;;=281.0^^35^482^123
 ;;^UTILITY(U,$J,358.3,8245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8245,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,8245,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,8245,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,8246,0)
 ;;=282.60^^35^482^111
 ;;^UTILITY(U,$J,358.3,8246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8246,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,8246,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,8246,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,8247,0)
 ;;=282.62^^35^482^112
 ;;^UTILITY(U,$J,358.3,8247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8247,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,8247,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,8247,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,8248,0)
 ;;=281.1^^35^482^124
 ;;^UTILITY(U,$J,358.3,8248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8248,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,8248,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,8248,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,8249,0)
 ;;=286.7^^35^482^54
 ;;^UTILITY(U,$J,358.3,8249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8249,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,8249,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,8249,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,8250,0)
 ;;=289.9^^35^482^120
 ;;^UTILITY(U,$J,358.3,8250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8250,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,8250,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,8250,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,8251,0)
 ;;=451.9^^35^482^121
 ;;^UTILITY(U,$J,358.3,8251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8251,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,8251,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,8251,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,8252,0)
 ;;=446.6^^35^482^122
 ;;^UTILITY(U,$J,358.3,8252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8252,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,8252,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,8252,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,8253,0)
 ;;=286.4^^35^482^125
 ;;^UTILITY(U,$J,358.3,8253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8253,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,8253,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,8253,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,8254,0)
 ;;=204.00^^35^482^1
 ;;^UTILITY(U,$J,358.3,8254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8254,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,8254,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,8254,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,8255,0)
 ;;=204.01^^35^482^3
 ;;^UTILITY(U,$J,358.3,8255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8255,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,8255,1,5,0)
 ;;=5^ALL,In Remission
 ;;^UTILITY(U,$J,358.3,8255,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,8256,0)
 ;;=204.10^^35^482^16
 ;;^UTILITY(U,$J,358.3,8256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8256,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,8256,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,8256,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,8257,0)
 ;;=204.11^^35^482^18
 ;;^UTILITY(U,$J,358.3,8257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8257,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,8257,1,5,0)
 ;;=5^CLL,In Remission
 ;;
 ;;$END ROU IBDEI0HO
